Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
Mallinckrodt
Fish and Richardson
Cipla
Dow
McKinsey
Farmers Insurance
Johnson and Johnson

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020591

« Back to Dashboard

NDA 020591 describes TARKA, which is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers. Additional details are available on the TARKA profile page.

The generic ingredient in TARKA is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.
Summary for 020591
Tradename:TARKA
Applicant:Abbvie
Ingredient:trandolapril; verapamil hydrochloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020591
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TARKA trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020591 NDA AbbVie Inc. 0074-3287 N 0074-3287-13
TARKA trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020591 NDA AbbVie Inc. 0074-3289 N 0074-3289-13

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength2MG;180MG
Approval Date:Oct 22, 1996TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength4MG;240MG
Approval Date:Oct 22, 1996TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength1MG;240MG
Approval Date:Oct 22, 1996TE:ABRLD:Yes

Expired US Patents for NDA 020591

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie TARKA trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020591-001 Oct 22, 1996 ➤ Sign Up ➤ Sign Up
Abbvie TARKA trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020591-004 Oct 22, 1996 ➤ Sign Up ➤ Sign Up
Abbvie TARKA trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020591-002 Oct 22, 1996 ➤ Sign Up ➤ Sign Up
Abbvie TARKA trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020591-003 Oct 22, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Medtronic
Healthtrust
Cerilliant
Fish and Richardson
Teva
Argus Health
McKinsey
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.